These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9222657)

  • 1. Fibrinogen, fibrinolysis and diabetes mellitus: a comment.
    Vague P; Juhan-Vague I
    Diabetologia; 1997 Jun; 40(6):738-40. PubMed ID: 9222657
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis.
    Morale M; De Negri F; Carmassi F
    Diabetologia; 1997 Jun; 40(6):735-7. PubMed ID: 9222656
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinogen and diabetes mellitus: is it time for intervention trials?
    Ceriello A
    Diabetologia; 1997 Jun; 40(6):731-4. PubMed ID: 9222655
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen and plasminogen activator inhibitor-1 level in peripheral arterial disease of type 2 diabetes patients.
    Hutajulu SH; Kurnianda J; Purwanto I; Asdie RH; Wiyono P; Asdie AH
    Acta Med Indones; 2006; 38(3):126-9. PubMed ID: 16953028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.
    Panahloo A; Yudkin JS
    J Cardiovasc Risk; 1997 Apr; 4(2):91-9. PubMed ID: 9304490
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.
    Vicari AM; Viganó D'Angelo S; Testa S; Comi G; Galardi G; Orsi E; D'Angelo A
    Horm Metab Res; 1992 Nov; 24(11):516-9. PubMed ID: 1452117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients.
    Schneider DJ; Nordt TK; Sobel BE
    Diabetes; 1993 Jan; 42(1):1-7. PubMed ID: 8420806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
    Skrha J; Hodinár A; Kvasnicka J; Hilgertová J
    Diabet Med; 1996 Sep; 13(9):800-5. PubMed ID: 8891455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
    Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW; Catto AJ; Carter AM; Grant PJ
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermographic measurement of skin temperature recovery time of extremities in patients with type 2 diabetes mellitus.
    Fujiwara Y; Inukai T; Aso Y; Takemura Y
    Exp Clin Endocrinol Diabetes; 2000; 108(7):463-9. PubMed ID: 11083067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early atherogenesis in diabetes mellitus.
    Schaper NC
    Diabet Med; 1996; 13 Suppl 1():S23-5. PubMed ID: 8741824
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
    Jae SY; Heffernan KS; Lee MK; Fernhall B; Park WH
    Am J Cardiol; 2008 Sep; 102(6):700-3. PubMed ID: 18773991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation profile in diabetes and its association with diabetic microvascular complications.
    Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP
    J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
    Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
    Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
    Rautio A; Boman K; Eriksson JW; Svensson MK
    Diab Vasc Dis Res; 2016 May; 13(3):183-91. PubMed ID: 26818227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factor hyperinsulinemia? Contra!].
    Ratzmann KP
    Dtsch Med Wochenschr; 2000 May; 125(21):678-80. PubMed ID: 10874908
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
    Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.